IBDEI0EJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6989,1,3,0)
 ;;=3^92060
 ;;^UTILITY(U,$J,358.3,6990,0)
 ;;=92240^^48^552^15^^^^1
 ;;^UTILITY(U,$J,358.3,6990,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6990,1,2,0)
 ;;=2^ICG Angiography
 ;;^UTILITY(U,$J,358.3,6990,1,3,0)
 ;;=3^92240
 ;;^UTILITY(U,$J,358.3,6991,0)
 ;;=92065^^48^552^16^^^^1
 ;;^UTILITY(U,$J,358.3,6991,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6991,1,2,0)
 ;;=2^Orthoptic/Pleoptic Training
 ;;^UTILITY(U,$J,358.3,6991,1,3,0)
 ;;=3^92065
 ;;^UTILITY(U,$J,358.3,6992,0)
 ;;=G0118^^48^552^13^^^^1
 ;;^UTILITY(U,$J,358.3,6992,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6992,1,2,0)
 ;;=2^Glaucoma Screen by Tech
 ;;^UTILITY(U,$J,358.3,6992,1,3,0)
 ;;=3^G0118
 ;;^UTILITY(U,$J,358.3,6993,0)
 ;;=S9150^^48^552^7^^^^1
 ;;^UTILITY(U,$J,358.3,6993,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6993,1,2,0)
 ;;=2^Evaluation by ocularist
 ;;^UTILITY(U,$J,358.3,6993,1,3,0)
 ;;=3^S9150
 ;;^UTILITY(U,$J,358.3,6994,0)
 ;;=76514^^48^552^5^^^^1
 ;;^UTILITY(U,$J,358.3,6994,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6994,1,2,0)
 ;;=2^Corneal Pachymetry
 ;;^UTILITY(U,$J,358.3,6994,1,3,0)
 ;;=3^76514
 ;;^UTILITY(U,$J,358.3,6995,0)
 ;;=87809^^48^552^2^^^^1
 ;;^UTILITY(U,$J,358.3,6995,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6995,1,2,0)
 ;;=2^Adenovirus Assay w/ Optic
 ;;^UTILITY(U,$J,358.3,6995,1,3,0)
 ;;=3^87809
 ;;^UTILITY(U,$J,358.3,6996,0)
 ;;=76513^^48^552^4^^^^1
 ;;^UTILITY(U,$J,358.3,6996,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6996,1,2,0)
 ;;=2^B-Scan,Ant Segmnt,Water Immersion
 ;;^UTILITY(U,$J,358.3,6996,1,3,0)
 ;;=3^76513
 ;;^UTILITY(U,$J,358.3,6997,0)
 ;;=373.32^^49^553^48
 ;;^UTILITY(U,$J,358.3,6997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6997,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,6997,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,6997,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,6998,0)
 ;;=373.00^^49^553^4
 ;;^UTILITY(U,$J,358.3,6998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6998,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,6998,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,6998,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,6999,0)
 ;;=373.2^^49^553^7
 ;;^UTILITY(U,$J,358.3,6999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6999,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,6999,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,6999,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,7000,0)
 ;;=374.84^^49^553^29
 ;;^UTILITY(U,$J,358.3,7000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7000,1,3,0)
 ;;=3^Eyelid Cysts
 ;;^UTILITY(U,$J,358.3,7000,1,4,0)
 ;;=4^374.84
 ;;^UTILITY(U,$J,358.3,7000,2)
 ;;=^269119
 ;;^UTILITY(U,$J,358.3,7001,0)
 ;;=374.87^^49^553^31
 ;;^UTILITY(U,$J,358.3,7001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7001,1,3,0)
 ;;=3^Eyelid Dermatochalasis
 ;;^UTILITY(U,$J,358.3,7001,1,4,0)
 ;;=4^374.87
 ;;^UTILITY(U,$J,358.3,7001,2)
 ;;=^269123
 ;;^UTILITY(U,$J,358.3,7002,0)
 ;;=375.15^^49^553^12
 ;;^UTILITY(U,$J,358.3,7002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7002,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,7002,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,7002,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,7003,0)
 ;;=374.01^^49^553^20
 ;;^UTILITY(U,$J,358.3,7003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7003,1,3,0)
 ;;=3^Entropion, Senile
 ;;^UTILITY(U,$J,358.3,7003,1,4,0)
 ;;=4^374.01
 ;;^UTILITY(U,$J,358.3,7003,2)
 ;;=Entropion, Senile^269074
 ;;^UTILITY(U,$J,358.3,7004,0)
 ;;=375.20^^49^553^68
 ;;^UTILITY(U,$J,358.3,7004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7004,1,3,0)
 ;;=3^Lacrimal,Epiphora
 ;;^UTILITY(U,$J,358.3,7004,1,4,0)
 ;;=4^375.20
